No Result
View All Result
  • Login
Tuesday, June 23, 2026
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Business

Syrma SGS Technology shares jump 5% after JV pact with Japan’s Kaga Electronics

by FeeOnlyNews.com
5 hours ago
in Business
Reading Time: 2 mins read
A A
0
Syrma SGS Technology shares jump 5% after JV pact with Japan’s Kaga Electronics
Share on FacebookShare on TwitterShare on LInkedIn


Shares of Syrma SGS Technology surged 4.84% to Rs 1,400.90 in Tuesday’s trading session after the electronics manufacturing services (EMS) company announced a strategic joint venture with Japan-based Kaga Electronics India Pvt. Ltd. to establish a state-of-the-art EMS manufacturing facility in India.

The partnership marks a significant step in Syrma’s efforts to strengthen its presence in the high-value electronics manufacturing segment while catering to the growing requirements of Japanese customers looking to expand their sourcing footprint in India.

According to the company’s regulatory filing, Syrma and Kaga signed an agreement to jointly establish, develop, and operate an advanced EMS manufacturing facility in India. The proposed venture will primarily focus on serving Japanese clients and leveraging the technical expertise and market reach of both partners.

Under the agreement, Syrma SGS Technology will hold up to a 60% stake in the proposed joint venture company (JVCo), while Kaga Electronics India will own up to 40%. Syrma plans to invest approximately Rs 15 crore in the venture, with Kaga contributing around Rs 10 crore. The transaction remains subject to customary regulatory approvals, conditions precedent, and closing requirements.

The governance structure of the JVCo will comprise a four-member board, with both partners nominating two directors each. The agreement also includes standard joint venture provisions such as rights of first refusal on share transfers, reserved matter protections, future funding mechanisms, rights issues, and capital structure safeguards.

Live Events

Importantly, the company clarified that Kaga is not related to Syrma’s promoter or promoter group, and the transaction does not qualify as a related-party transaction.Market participants viewed the collaboration positively, as it strengthens Syrma’s manufacturing capabilities and positions the company to benefit from increasing global supply-chain diversification and the growing trend of Japanese companies expanding production and sourcing operations in India.The announcement triggered buying interest in the counter, pushing Syrma SGS Technology shares nearly 5% higher during the session.

Share Price Performance

Syrma SGS Technology has delivered a strong rally over recent periods, gaining nearly 80% in the last three months and surging around 165% over the past year. The company currently commands a market capitalisation of approximately Rs 25,766 crore. During intraday trade today, the stock also touched a fresh 52-week high of Rs 1,410, reflecting strong bullish momentum.

From a technical standpoint, the stock appears stretched in the short term. The 14-day Relative Strength Index (RSI) stands at 76, a level typically considered overbought, suggesting the possibility of near-term consolidation or a pullback. However, the broader trend remains firmly positive, with the stock trading above all 8 key simple moving averages (SMAs), underscoring sustained bullish strength across timeframes.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)



Source link

Tags: electronicsJapansjumpKagapactSGSsharesSyrmaTechnology
ShareTweetShare
Previous Post

Canada’s Inflation Problem Is Far From Over

Next Post

10 years after Brexit: 7 prime ministers, a demographic slide, and a 6% GDP hit

Related Posts

BIO 2026: Drug manufacturers band together to tackle employment challenges

BIO 2026: Drug manufacturers band together to tackle employment challenges

by FeeOnlyNews.com
June 23, 2026
0

US-based drugmakers are meeting rising demand not by competing for local talent, but by collaborating through trade associations to support...

Stock index futures plunge amid broader tech selloff (SPX:)

Stock index futures plunge amid broader tech selloff (SPX:)

by FeeOnlyNews.com
June 23, 2026
0

Jun 23, 2026, 4:16 AM ETS&P 500 Futures (SPX), INDU, US100:INDPNW, IBM, BBY, GRMN, SMCI, DD, US10Y, US2Y, US30YBy: Sinchita...

10 years after Brexit: 7 prime ministers, a demographic slide, and a 6% GDP hit

10 years after Brexit: 7 prime ministers, a demographic slide, and a 6% GDP hit

by FeeOnlyNews.com
June 23, 2026
0

A decade ago today, June 23rd, 2016, 52% of the British electorate voted to leave the European Union. It was...

Jivial Industries IPO opens today. Check GMP, price band, subscription and other details

Jivial Industries IPO opens today. Check GMP, price band, subscription and other details

by FeeOnlyNews.com
June 22, 2026
0

Jivial Industries' SME IPO will open for subscription on Tuesday, with the grey market indicating a subdued listing. The company's...

Meet a British businessman who doesn’t regret his Brexit vote. He says rejoining the EU would be ‘re-boarding the Titanic’ while giving up life vests

Meet a British businessman who doesn’t regret his Brexit vote. He says rejoining the EU would be ‘re-boarding the Titanic’ while giving up life vests

by FeeOnlyNews.com
June 22, 2026
0

Simon Boyd’s firm makes prefabricated steel structures on the south coast of England and ships them to customers as far...

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth .5B

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B

by FeeOnlyNews.com
June 22, 2026
0

Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK Biopharmaceuticals to help develop...

Next Post
10 years after Brexit: 7 prime ministers, a demographic slide, and a 6% GDP hit

10 years after Brexit: 7 prime ministers, a demographic slide, and a 6% GDP hit

Keir Starmer Resigns: Can Anyone Survive as Prime Minister in Today’s Britain?

Keir Starmer Resigns: Can Anyone Survive as Prime Minister in Today’s Britain?

  • Trending
  • Comments
  • Latest
Entry-Level Rentals Are Disappearing—Here’s How Landlords Can Fill the Gap

Entry-Level Rentals Are Disappearing—Here’s How Landlords Can Fill the Gap

June 18, 2026
Trump reportedly pressed FDA chief to authorize mango and blueberry vapes after years of rejection

Trump reportedly pressed FDA chief to authorize mango and blueberry vapes after years of rejection

May 7, 2026
Synopsys targets .61B revenue for 2026 while advancing joint AI solutions and accelerating Ansys integration (NASDAQ:SNPS)

Synopsys targets $9.61B revenue for 2026 while advancing joint AI solutions and accelerating Ansys integration (NASDAQ:SNPS)

December 10, 2025
Trump claims Iran deal is ‘unconditional surrender’: Axios

Trump claims Iran deal is ‘unconditional surrender’: Axios

June 18, 2026
Strait Outta Hormuz: Getting the Iran Oil Story Straight

Strait Outta Hormuz: Getting the Iran Oil Story Straight

June 12, 2026
Rothbard on Scientism | Mises Institute

Rothbard on Scientism | Mises Institute

June 5, 2026
Lies, Damn Lies, and the History of Capitalism

Lies, Damn Lies, and the History of Capitalism

0
The Fed Signals a Reversal in Rates

The Fed Signals a Reversal in Rates

0
266. “I carry the household, the bills, and the stress”

266. “I carry the household, the bills, and the stress”

0
Bangladesh Bank announces Tk 900cr fund for startups

Bangladesh Bank announces Tk 900cr fund for startups

0
Report: South Africa Social Tensions Survey 2026

Report: South Africa Social Tensions Survey 2026

0
The planning prospects who are ‘hidden in plain sight’

The planning prospects who are ‘hidden in plain sight’

0
The Fed Signals a Reversal in Rates

The Fed Signals a Reversal in Rates

June 23, 2026
BIO 2026: Drug manufacturers band together to tackle employment challenges

BIO 2026: Drug manufacturers band together to tackle employment challenges

June 23, 2026
266. “I carry the household, the bills, and the stress”

266. “I carry the household, the bills, and the stress”

June 23, 2026
Lies, Damn Lies, and the History of Capitalism

Lies, Damn Lies, and the History of Capitalism

June 23, 2026
CZ Says Hyperliquid Found A No-KYC Niche Binance Cannot Touc

CZ Says Hyperliquid Found A No-KYC Niche Binance Cannot Touc

June 23, 2026
Why Speed is the Most Underrated Advantage in Today’s Stock Market?

Why Speed is the Most Underrated Advantage in Today’s Stock Market?

June 23, 2026
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • The Fed Signals a Reversal in Rates
  • BIO 2026: Drug manufacturers band together to tackle employment challenges
  • 266. “I carry the household, the bills, and the stress”
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.